Next Quarterly Earnings
Tuesday, August 11, 2026
CW 33
Pre-Market
In 37 days
Ligand Pharmaceuticals is a biopharmaceutical company that develops and markets innovative medicines. Through its unique licensing model, Ligand focuses on identifying, acquiring, and developing promising therapeutics for treating various diseases. The company strengthens its pipeline and generates revenue through partnerships with leading pharmaceutical companies.